2,610
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Development of linear and nonlinear predictive QSAR models and their external validation using molecular similarity principle for anti-HIV indolyl aryl sulfones

&
Pages 980-995 | Received 19 Sep 2007, Accepted 29 Oct 2007, Published online: 20 Oct 2008

References

  • K Roy, and J Leonard. (2004). QSAR modeling of HIV-1 reverse transcriptase inhibitor 2-amino-6-arylsulfonylbenzonitriles and congeners using molecular connectivity and E-state parameters. Bioorg Med Chem 12:745–754.
  • www.unaids.org
  • pathmicro.med.sc.edu/lecture/hiv2000.htm.
  • www.rhodes.edu/biology/glindquester/viruses/pagespass/hiv/hiv.html
  • uhavax.hartfold.edu/bugl/hiv.htm
  • www.aegis.com/topics/basics/hivandaids.html
  • S Villar, L Santana, and E Uriate. (2006). PNN model for in silico evaluation of anti-HIV activity and mechanism of action. J Med Chem 49 (3):118–1124.
  • YS Prabhakar, RK Rawal, MK Gupta, VR Solomon, and SB Katti. (2005). Topological descriptors in modeling the HIV inhibitory activity of 2-aryl 3-pyridyl-thiazolidin 4-ones. Comb Chem High Throughput Screen 8 (5):431–437.
  • CL Senese, and AJ Hopfinger. (2003). Receptor-independent 4D-QSAR analysis of a set of norstatine derived inhibitors of HIV-1 protease. J Chem Inf Comput Sci 43:1297–1307.
  • MT Makhija, and VM Kulkarni. (2002). 3D-QSAR and molecular modeling of HIV-1 integrase inhibitors. J Comp Aided Mol Des 16 (3):181–200.
  • JK Buolamwini, and H Assefa. (2002). CoMFA and CoMSIA 3D-QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: Exploration of a binding mode at the active site. J Med Chem 45 (4):841–852.
  • T Niwa. (2004). Prediction of biological targets using PNN and atom-type descriptors. J Med Chem 47 (10):2645–2650.
  • D Weekes, and GB Fogel. (2003). Evolutionary optimization, backpropagation and data preparation issues in QSAR modeling of HIV inhibition by HEPT derivatives. Biosystems 72:149–158.
  • CL Senese, and AJ Hopfinger. (2003). A simple clustering technique to improve QSAR model selection and predictivity: Application to a receptor independent 4D-QSAR analysis of cyclic urea derived inhibitors of HIV-1 protease. J Chem Inf Comp Sci 43 (6):2180–2193.
  • P Pungpo, and S Hannongbua. (2000). 3D-QSAR study on HIV-1 RT inhibitors in the class of dipyridodiazepinone derivatives, using CoMFA. J Mol Graph Model 18 (6):581–590. & 601
  • R Ragno, M Artico, GD Martino, GL Regina, A Coluccia, AD Pasquali, and R Silvestri. (2005). Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-Hydroxyethyl) carboxamide and N-(2-Hydroxyethyl) carbohydrazide derivatives. J Med Chem 48:213–223.
  • JT Leonard, and K Roy. (2004). Classical QSAR modeling of HIV-1 reverse transcriptase inhibitor 2-amino-6-arylsulfonylbenzonitriles and congener. QSAR Comb Sci 23:23–35.
  • JT Leonard, and K Roy. (2003). QSAR modeling of anti-HIV activities of alkenyldiarylmethanes using topological and physicochemical descriptors. Drug Des Discov 18:165–180.
  • JT Leonard, and K Roy. (2004). Classical QSAR modeling of CCR5 receptor binding affinity of substituted benzylpyrazoles. QSAR Comb Sci 23:387–398.
  • K Roy, and JT Leonard. (2005). Classical QSAR modeling of anti-HIV 2,3-diaryl-1,3-thiazolidin-4-ones. QSAR Comb Sci 24:579–592.
  • K Roy, and JT Leonard. (2005). QSAR by LFER model of cytotoxicity data of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives using principal component factor analysis and genetic function approximation. Bioorg Med Chem 13:2967–2973.
  • K Roy, and JT Leonard. (2006). Topological QSAR modeling of cytotoxicity data of anti-HIV5-phenyl-1-phenylamino-imidazole derivatives using GFA, G/PLS, FA and PCRA techniques. Indian J Chem 45A:126–137.
  • K Roy, and JT Leonard. (2005). QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N phenylpropylamine derivatives as potent CCR5 antagonists. J Chem Inf Model 45:1352–1368.
  • JT Leonard, and K Roy. (2006). QSAR by LFER model of HIV protease inhibitor mannitol derivatives using FA-MLR, PCRA, and PLS techniques. Bioorg Med Chem 14:1039–1046.
  • JT Leonard, K Roy, and QSAR Comparative. (2006). modeling of CCR5 receptor binding affinities of substituted 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas. Bioorg Med Chem Lett 16:4467–4474.
  • R Ragno, A Coluccia, GL Regina, GD Martino, F Piscitelli, A Lavecchia, E Novellino, A Bergamini, C Ciaprini, A Sinistro, G Maga, E Crespan, M Artico, and R Silvestri. (2006). Design molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide. J Med Chem 49:3172–3184.
  • C Hansch, A Leo, and D Hoekman. Exploring QSAR Hydrophobic, electronic and steric constants. Washington, DC: American Chemical Society; (1995).
  • Cerius2 Version 4.10 is a product of Accelrys Inc., San Diego, CA.
  • L Eriksson, J Jaworska, AP Worth, MTD Cronin, RM McDowell, and P Gramatica. (2003). Methods for reliability and uncertainty assessment and for applicability evaluations of classification and regression-based QSARs. Environ Health Perspect 111:1361–1375.
  • R Guha, and PC Jurs. (2005). Determining the validity of a QSAR Model-A classification approach. J Chem Inf Model 45:65–73.
  • JT Leonard, and K Roy. (2006). On selection of training and test sets for the development of predictive QSAR models. QSAR Comb Sci 25 (3):235–251.
  • BS Everitt, S Landau, and M Leese. Cluster analysis. Edward Arnold: London; (2001).
  • RB Kowalski, S Wold. Handbook of statistics. Amsterdam: North Holland Publishing Company; (1982).
  • GM Downs, P. Willett. In: H van de Waterbeemd, editor. Advanced computer assisted techniques in drug discovery. Weinheim (Ger.): VCH; (1995). p 111–130.
  • RB Darlington. Regression and linear models. New York: McGraw-Hill; (1990).
  • S Wold. In: H van de Waterbeemd, editor. Chemometric methods in molecular design. Weinheim: VCH; (1995). p 195.
  • Y Fan, LM Shi, KW Kohn, Y Pommier, JN Weinstein. (2001). Quantitative structure–antitumor activity relationships of camptothecin analogues: Cluster analysis and genetic algorithm-based studies. J Med Chem 44:3254.
  • R Franke. Theoretical drug design methods. Amsterdam: Elsevier, (1984). p 184.
  • R Franke, A Gruska. Chemometric methods in molecular design. In: H van de Waterbeemd, editor. Weinheim: VCH; (1995). p 113.
  • D Rogers, and AJ Hopfinger. (1994). Application of genetic function approximation to quantitative structure–activity relationships and quantitative structure–property relationships. J Chem Inf Comput Sci 34:854–866.
  • Y Tang, HL Jiang, KX Chen, and RY Ji. (1996). QSAR study of artemisinin (Qinghaosu) derivatives using neural network method. Indian J Chem 35B:325–332.
  • GW Snedecor, WG Cochran. . In: H van de Waterbeemd, editor. Statistical methods. New Delhi: Oxford and IBH; (1967). p 381.
  • S Wold, L Eriksson. In: H van de Waterbeemd. , editor. Chemometric methods in molecular designWeinheim: VCH; (1995). p 312.
  • AK Debnath. In AK Ghose, and VN Viswanadhan, editors. Combinatorial library design and evaluation. New York: Marcel Dekker Inc. (2001). p 73.
  • MINITAB is a statistical software of Minitab Inc.; USA.
  • SPSS is a statistical software of SPSS Inc.; USA.
  • STATISTICA is a statistical software of STATSOFT Inc.; USA.
  • DJ Livingstone, and DW Salt. (2005). Judging the significance of multiple linear regression models. J Med Chem 48:661–663.
  • http://www.port.ac.uk/research/cmd/research/selectionbiasinmultipleregression/
  • P Gramatica. (2007). Principles of QSAR models validation: Internal and external. QSAR Comb Sci 26:694–701.
  • K Roy. On some aspects of validation of predictive QSAR models. Expert Opin Drug Discov 2007;2:1567–1577.
  • A Golbraikh, and A Tropsha. (2002). Beware of q2!. J Mol Graphics Mod 20:269–276.
  • P Roy, and K Roy. (2007). On some aspects of variable selection for partial least squares regression models. QSAR Comb Sci 26: http://dx.doi.org/10.1002/qsar.200710043

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.